Monthly information related to total number of voting rights and shares composing the share capital _September 30, 2023
October 23, 2023 12:00 ET
|
Phaxiam Therapeutics S.A.
Monthly information related to total number of voting rights and shares composing the share capital _September 30, 2023. Article 223-16 of general regulation of French Autorité des Marchés...
PHAXIAM Therapeutics annonce un niveau de performance élevé de ses deux phages anti-Staphylococcus aureus sur des souches cliniques
October 09, 2023 16:05 ET
|
Phaxiam Therapeutics S.A.
PHAXIAM Therapeutics annonce un niveau de performance élevé de ses deux phages anti-Staphylococcus aureus sur des souches cliniques Les données obtenues à partir du phagogramme développé par PHAXIAM,...
PHAXIAM Therapeutics announces high coverage performance of its two anti-Staphylococcus aureus phages over clinical strains
October 09, 2023 16:05 ET
|
Phaxiam Therapeutics S.A.
PHAXIAM Therapeutics announces high coverage performanceof its two anti-Staphylococcus aureus phages over clinical strains Data from PHAXIAM’s phagogram, first CE-marked Phage Susceptibility Test...
PHAXIAM reçoit un avis de conformité du Nasdaq
October 04, 2023 16:05 ET
|
Phaxiam Therapeutics S.A.
PHAXIAM reçoit un avis de conformité du Nasdaq Lyon (France) et Cambridge (MA, US), le 4 octobre 2023, 22h05 CEST – PHAXIAM Therapeutics (Nasdaq & Euronext : PHXM), annonce aujourd'hui avoir reçu...
PHAXIAM Receives Compliance Notice from Nasdaq
October 04, 2023 16:05 ET
|
Phaxiam Therapeutics S.A.
PHAXIAM Receives Compliance Notice from Nasdaq Lyon (France) et Cambridge (MA, US), October 4, 2023, at 10:05 pm CEST – PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM), today announced that it has...
PHAXIAM Therapeutics et Vetophage annoncent une collaboration de recherche stratégique
October 03, 2023 16:05 ET
|
Phaxiam Therapeutics S.A.
PHAXIAM Therapeutics et Vetophage annoncent une collaboration de recherche stratégique Partenariat de recherche stratégique entre PHAXIAM Therapeutics et Vetophage, société de biotechnologie...
PHAXIAM Therapeutics and Vetophage Announce Strategic Research Collaboration
October 03, 2023 16:05 ET
|
Phaxiam Therapeutics S.A.
PHAXIAM Therapeutics and Vetophage Announce Strategic Research Collaboration Strategic research partnership between PHAXIAM Therapeutics and Vetophage, a biotechnology company specialized in...
RAPPORT FINANCIER SEMESTRIEL 30 JUIN 2023 PHAXIAM
September 26, 2023 16:34 ET
|
Phaxiam Therapeutics S.A.
Rapport Financier Semestriel 30 Juin 2023 PHAXIAM
Pièce jointe
PHXM_Master RFA 2023_06 (1)
...
Rapport Financier Semestriel 30 Juin 2023 PHAXIAM
September 26, 2023 16:34 ET
|
Phaxiam Therapeutics S.A.
Rapport Financier Semestriel 30 Juin 2023 PHAXIAM
Attachment
PHXM_Master RFA 2023_06 (1)
...
PHAXIAM Provides Business and Financial Update For the First Half of 2023
September 21, 2023 16:05 ET
|
Phaxiam Therapeutics S.A.
PHAXIAM Provides Business and Financial UpdateFor the First Half of 2023 Conference call and webcast (English) on Monday, September 25, 2023at 8:30am ET / 2:30pm CEST Formation of PHAXIAM...